Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Takiue, Keiichi ^a   Sugiyama, Hitoshi ^a   Inoue, Tatsuyuki ^a,b   Morinaga, Hiroshi ^a   Kikumoto, Yoko ^a   Kitagawa, Masashi ^a   Kitamura, Shinji ^a   Maeshima, Yohei ^a   Wang, Da Hong ^a   Masuoka, Noriyoshi ^c   Ogino, Keiki ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; DOXORUBICIN; LIPID PEROXIDE; TOLL LIKE RECEPTOR 4;

ADRENAL CORTEX ATROPHY; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C3H MOUSE; CATALASE DEFICIENCY; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; ENZYME ACTIVITY; GENE MUTATION; GLOMERULAR DYSFUNCTION; GLOMERULOSCLEROSIS; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; MORPHOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; WILD TYPE; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE PREDISPOSITION; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY;

ACATALASIA; ALBUMINURIA; ANIMALS; CATALASE; DISEASE SUSCEPTIBILITY; DOXORUBICIN; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT;

EID: 84862789623     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-14     Document Type: Article

References (42)

1. Hydroperoxide metabolism in mammalian organs. Chance B, Sies H, Boveris A, Physiol Rev 1979 59 3 527 605 37532 (Pubitemid 9236599)
2. Evolution of catalases from bacteria to humans. Zamocky M, Furtmuller PG, Obinger C, Antioxid Redox Signal 2008 10 9 1527 1548 10.1089/ars.2008.2046 18498226 (Pubitemid 351931928)
3. Progressive oral gangrene probably due to lack of catalase in the blood (acatalasaemia); report of nine cases. Takahara S, Lancet 1952 2 6745 1101 1104 12991731
4. Acatalasemia. Ogata M, Hum Genet 1991 86 4 331 340 1999334
5. Mammalian acatalasemia: the perspectives of bioinformatics and genetic toxicology. Ogata M, Wang DH, Ogino K, Acta Med Okayama 2008 62 6 345 361 19122680
6. Blood catalsase polymorphism: some immunological aspects. Feinstein RN, Suter H, Jaroslow BN, Science 1968 159 815 638 640 10.1126/science.159.3815.638 4975476
7. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Haas M, Spargo BH, Coventry S, Am J Kidney Dis 1995 26 5 740 750 10.1016/0272-6386(95)90437-9 7485126
8. Therapeutic targets in focal and segmental glomerulosclerosis. Lavin PJ, Gbadegesin R, Damodaran TV, Winn MP, Curr Opin Nephrol Hypertens 2008 17 4 386 392 10.1097/MNH.0b013e32830464f4 18660675
9. Induction of proteinuria by adriamycin or bovine serum albumin in the mouse. Chen A, Wei CH, Sheu LF, Ding SL, Lee WH, Nephron 1995 69 3 293 300 10.1159/000188473 7753263
10. Experimental focal segmental glomerulosclerosis in mice. Chen A, Sheu LF, Ho YS, Lin YF, Chou WY, Chou TC, Lee WH, Nephron 1998 78 4 440 452 10.1159/000044974 9578071 (Pubitemid 28154166)
11. Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis. Deman A, Ceyssens B, Pauwels M, Zhang J, Houte KV, Verbeelen D, Van den Branden C, Nephrol Dial Transplant 2001 16 1 147 150 10.1093/ndt/16.1.147 11568278 (Pubitemid 32051489)
12. Nitric oxide protection against adriamycin-induced tubulointerstitial injury. Oteki T, Nagase S, Shimohata H, Hirayama A, Ueda A, Yokoyama H, Yoshimura T, Free Radic Res 2008 42 2 154 161 10.1080/10715760701840047 18297608 (Pubitemid 351298364)
13. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. Guo J, Ananthakrishnan R, Qu W, Lu Y, Reiniger N, Zeng S, Ma W, Rosario R, Yan SF, Ramasamy R, et al. J Am Soc Nephrol 2008 19 5 961 972 10.1681/ASN.2007101109 18256352
14. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, et al. J Am Soc Nephrol 2005 16 9 2690 2701 10.1681/ASN.2004121084 15987752
15. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Shioji K, Kishimoto C, Nakamura H, Masutani H, Yuan Z, Oka S, Yodoi J, Circulation 2002 106 11 1403 1409 10.1161/01.CIR.0000027817.55925.B4 12221060 (Pubitemid 35013046)
16. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yamasaki Y, Masuoka N, Yamada M, Kira S, Makino H, Kidney Int 2005 68 3 1018 1031 10.1111/j.1523-1755.2005.00494.x 16105032 (Pubitemid 43246418)
17. Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Sunami R, Sugiyama H, Wang DH, Kobayashi M, Maeshima Y, Yamasaki Y, Masuoka N, Ogawa N, Kira S, Makino H, Am J Physiol Renal Physiol 2004 286 6 1030 F1038 10.1152/ajprenal.00266.2003 14722014 (Pubitemid 38656356)
18. Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice. Kikumoto Y, Sugiyama H, Inoue T, Morinaga H, Takiue K, Kitagawa M, Fukuoka N, Saeki M, Maeshima Y, Wang DH, et al. Biochim Biophys Acta 2010 1802 2 240 246 19883754
19. Efficacy of darbepoetin in doxorubicin-induced cardiorenal injury in rats. Noiri E, Nagano N, Negishi K, Doi K, Miyata S, Abe M, Tanaka T, Okamoto K, Hanafusa N, Kondo Y, et al. Nephron Exp Nephrol 2006 104 1 6 e14 10.1159/000093258 16707910
20. Effects of gestational diethylstilbestrol treatment on male and female gonads during early embryonic development. Ikeda Y, Tanaka H, Esaki M, Endocrinology 2008 149 8 3970 3979 10.1210/en.2007-1599 18436715
21. Development of Angiotensin II-induced Abdominal Aortic Aneurysms Is Independent of Catalase in Mice. Uchida HA, Sugiyama H, Takiue K, Kikumoto Y, Inoue T, Makino H, J Cardiovasc Pharmacol 2011 58 6 633 638 10.1097/FJC. 0b013e3182317196 21885993
22. Detection of mixed clarithromycin-resistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces. Noguchi N, Rimbara E, Kato A, Tanaka A, Tokunaga K, Kawai T, Takahashi S, Sasatsu M, J Med Microbiol 2007 56 Pt 9 1174 1180 17761479 (Pubitemid 47477188)
23. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al. Science 1998 282 5396 2085 2088 9851930 (Pubitemid 29001265)
24. Apoptosis and extracellular matrix-cell interactions in kidney disease. Makino H, Sugiyama H, Kashihara N, Kidney Int Suppl 2000 77 67 S75 10997693
25. Regulation of survival and death of mesangial cells by extracellular matrix. Sugiyama H, Kashihara N, Maeshima Y, Okamoto K, Kanao K, Sekikawa T, Makino H, Kidney Int 1998 54 4 1188 1196 10.1046/j.1523-1755.1998.00116.x 9767534 (Pubitemid 28449905)
26. An ancestral haplotype defines susceptibility to doxorubicin nephropathy in the laboratory mouse. Zheng Z, Pavlidis P, Chua S, D'Agati VD, Gharavi AG, J Am Soc Nephrol 2006 17 7 1796 1800 10.1681/ASN.2005121373 16775033 (Pubitemid 44036163)
27. Inducible rodent models of acquired podocyte diseases. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, et al. Am J Physiol Renal Physiol 2009 296 2 213 F229 18784259
28. A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Zheng Z, Schmidt-Ott KM, Chua S, Foster KA, Frankel RZ, Pavlidis P, Barasch J, D'Agati VD, Gharavi AG, Proc Natl Acad Sci USA 2005 102 7 2502 2507 10.1073/pnas.0409786102 15699352 (Pubitemid 40279406)
29. Signaling danger: toll-like receptors and their potential roles in kidney disease. Anders HJ, Banas B, Schlondorff D, J Am Soc Nephrol 2004 15 4 854 867 10.1097/01.ASN.0000121781.89599.16 15034087 (Pubitemid 38375304)
30. Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistance. Brideau G, Doucet A, BMC Nephrol 2010 11 15 10.1186/1471-2369-11-15 20649959
31. Depletion of gammadelta T cells exacerbates murine adriamycin nephropathy. Wu H, Wang YM, Wang Y, Hu M, Zhang GY, Knight JF, Harris DC, Alexander SI, J Am Soc Nephrol 2007 18 4 1180 1189 10.1681/ASN.2006060622 17329577 (Pubitemid 46536904)
32. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT, J Immunol 2006 177 6 4094 4102 16951374 (Pubitemid 44359944)
33. The role of catalase in pulmonary fibrosis. Odajima N, Betsuyaku T, Nagai K, Moriyama C, Wang DH, Takigawa T, Ogino K, Nishimura M, Respir Res 2010 11 183 10.1186/1465-9921-11-183 21190578
34. Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice. Fukuoka N, Sugiyama H, Inoue T, Kikumoto Y, Takiue K, Morinaga H, Nakao K, Maeshima Y, Asanuma M, Wang DH, et al. Am J Nephrol 2008 28 4 661 668 10.1159/000121357 18337633 (Pubitemid 351832454)
35. Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice. Godin N, Liu F, Lau GJ, Brezniceanu ML, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS, Kidney Int 2010 77 12 1086 1097 10.1038/ki.2010.63 20237455
36. Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress. Injac R, Boskovic M, Perse M, Koprivec-Furlan E, Cerar A, Djordjevic A, Strukelj B, Pharmacol Rep 2008 60 5 742 749 19066422
37. Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. Sheerin NS, Risley P, Abe K, Tang Z, Wong W, Lin T, Sacks SH, FASEB J 2008 22 4 1065 1072 18039928 (Pubitemid 351519961)
38. Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice. Morelli D, Menard S, Colnaghi MI, Balsari A, Cancer Res 1996 56 9 2082 2085 8616854 (Pubitemid 26120599)
39. Hereditary catalase deficiencies and increased risk of diabetes. Goth L, Eaton JW, Lancet 2000 356 9244 1820 1821 10.1016/S0140-6736(00)03238-4 11117918
40. Oxidative stress and homocysteine metabolism in patients with lupus nephritis. Moroni G, Novembrino C, Quaglini S, De Giuseppe R, Gallelli B, Uva V, Montanari V, Messa P, Bamonti F, Lupus 2010 19 1 65 72 10.1177/0961203309346906 19933721
41. Glomerular cell apoptosis in human lupus nephritis. Makino H, Sugiyama H, Yamasaki Y, Maeshima Y, Wada J, Kashihara N, Virchows Arch 2003 443 1 67 77 10.1007/s00428-003-0827-x 12750884 (Pubitemid 36920953)
42. Induction of renal tubular cell apoptosis in focal segmental glomerulosclerosis: roles of proteinuria and Fas-dependent pathways. Erkan E, Garcia CD, Patterson LT, Mishra J, Mitsnefes MM, Kaskel FJ, Devarajan P, J Am Soc Nephrol 2005 16 2 398 407 10.1681/ASN.2003100861 15601749 (Pubitemid 41725135)